(Q34341985)

1 August 2017

1 reference

title

Proteasome inhibitors: from research tools to drug candidates (English)

1 reference

1 August 2017

Kisselev AF

1

1 reference

1 August 2017

Goldberg AL

series ordinal

2

1 reference

1 August 2017

publication date

1 August 2001

1 reference

1 August 2017

published in

Chemistry and Biology

1 reference

1 August 2017

volume

8

1 reference

1 August 2017

issue

8

1 reference

1 August 2017

page(s)

739-758

1 reference

Lessons from the discovery of the ubiquitin system

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Involvement of the proteasome in various degradative processes in mammalian cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

The ubiquitin-proteasome proteolytic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

How the cyclin became a cyclin: regulated proteolysis in the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

1 reference

7 January 2021

Ubiquitin-mediated degradation of active Src tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Activation of protein kinase C triggers its ubiquitination and degradation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Degradation of cell proteins and the generation of MHC class I-presented peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Peptides accelerate their uptake by activating a ubiquitin-dependent proteolytic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Ubiquitin-mediated proteolysis in learning and memory

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

A role for the proteasome in the light response of the timeless clock protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Targeted destabilization of HY5 during light-regulated development of Arabidopsis.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Rapid degradation of a large fraction of newly synthesized proteins by proteasomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Ca2+-free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by 26 S proteasomes without ubiquitination

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Multiple proteolytic systems, including the proteasome, contribute to CFTR processing

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Degradation of CFTR by the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Degradation of a mutant secretory protein, alpha1-antitrypsin Z, in the endoplasmic reticulum requires proteasome activity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

The 26S proteasome: a molecular machine designed for controlled proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

The regulatory complex of Drosophila melanogaster 26S proteasomes. Subunit composition and localization of a deubiquitylating enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Structure and functions of the 20S and 26S proteasomes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

In vivo assembly of the proteasomal complexes, implications for antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

The proteasome activator 11 S REG (PA28) and class I antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

The proteasome: paradigm of a self-compartmentalizing protease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Structure of 20S proteasome from yeast at 2.4 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

A gated channel into the proteasome core particle

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Conformational constraints in protein degradation by the 20S proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

The axial channel of the proteasome core particle is gated by the Rpt2 ATPase and controls both substrate entry and product release

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

An archaebacterial ATPase, homologous to ATPases in the eukaryotic 26 S proteasome, activates protein breakdown by 20 S proteasomes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Biochemical and physical properties of the Methanococcus jannaschii 20S proteasome and PAN, a homolog of the ATPase (Rpt) subunits of the eucaryal 26S proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

PAN, the proteasome-activating nucleotidase from archaebacteria, is a protein-unfolding molecular chaperone

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

The multicatalytic proteinase complex, a major extralysosomal proteolytic system

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Components of the bovine pituitary multicatalytic proteinase complex (proteasome) cleaving bonds after hydrophobic residues

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Cleavage of Pro-X and Glu-X bonds catalyzed by the branched chain amino acid preferring activity of the bovine pituitary multicatalytic proteinase complex (20S proteasome).

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Evidence for the existence of a non-catalytic modifier site of peptide hydrolysis by the 20 S proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Lack of proteasome active site allostery as revealed by subunit-specific inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

HslV-HslU: A novel ATP-dependent protease complex in Escherichia coli related to the eukaryotic proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

A protein catalytic framework with an N-terminal nucleophile is capable of self-activation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Proteasome from Thermoplasma acidophilum: a threonine protease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Why does threonine, and not serine, function as the active site nucleophile in proteasomes?

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Reactions of [14C]-3,4-dichloroisocoumarin with subunits of pituitary and spleen multicatalytic proteinase complexes (proteasomes).

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Emerging roles for cysteine proteases in human biology

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Calpain inhibition: an overview of its therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

14-3-3s regulate global cleavage of their diverse binding partners in sugar-starved Arabidopsis cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Active site-directed inhibitors of Rhodococcus 20 S proteasome. Kinetics and mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Total synthesis and biological activity of lactacystin, omuralide and analogs

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

A giant protease with potential to substitute for some functions of the proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Vinyl Sulfones as Mechanism-Based Cysteine Protease Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Global analysis of proteasomal substrate specificity using positional-scanning libraries of covalent inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Inhibitors of the chymotrypsin-like activity of proteasome based on di- and tri-peptidyl alpha-keto aldehydes (glyoxals)

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

P'-extended alpha-ketoamide inhibitors of proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

A new structural class of proteasome inhibitors that prevent NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Bivalency as a principle for proteasome inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

How an inhibitor of the HIV-I protease modulates proteasome activity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

The antitumor drug aclacinomycin A, which inhibits the degradation of ubiquitinated proteins, shows selectivity for the chymotrypsin-like activity of the bovine pituitary 20 S proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Proteasome inhibitors cause induction of heat shock proteins and trehalose, which together confer thermotolerance in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Activation of the cell death program by inhibition of proteasome function

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Increased sensitivity of CLL-derived lymphocytes to apoptotic death activation by the proteasome-specific inhibitor lactacystin

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

p53-dependent induction of apoptosis by proteasome inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2).

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Detailed analysis of cell cycle kinetics upon proteasome inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

p53-dependent cell cycle arrest induced by N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal in platelet-derived growth factor-stimulated human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Inhibition of TNF-induced apoptosis by NF-kappa B.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Cells adapted to the proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survival

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Proteasomes play an essential role in thymocyte apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Inhibition of etoposide-induced apoptosis with peptide aldehyde inhibitors of proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

The proteasome is involved in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

New agents in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

A proteolytic system that compensates for loss of proteasome function

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Two new proteases in the MHC class I processing pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Activators and target genes of Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Proteasome inhibition: A novel mechanism to combat asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Ubiquitin in retrovirus assembly: actor or bystander?

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

A ubiquitin-based tagging system for controlled modulation of protein stability

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

Structural basis for the activation of 20S proteasomes by 11S regulators

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2801%2900056-4

7 January 2021

10.1016/S1074-5521(01)00056-4

Identifiers

DOI

1 reference

1 August 2017

1 reference